Subscribe to the gold package and get unlimited access to Shamra Academy
Register a new userArtificial intelligence and the future of diagnostic and therapeutic radiopharmaceutical development: in Silico smart molecular design
177
0
0.0
(
0
)
Ask ChatGPT about the research
No Arabic abstract
Novel diagnostic and therapeutic radiopharmaceuticals are increasingly becoming a central part of personalized medicine. Continued innovation in the development of new radiopharmaceuticals is key to sustained growth and advancement of precision medicine. Artificial intelligence (AI) has been used in multiple fields of medicine to develop and validate better tools for patient diagnosis and therapy, including in radiopharmaceutical design. In this review, we first discuss common in silico approaches and focus on their utility and challenges in radiopharmaceutical development. Next, we discuss the practical applications of in silico modeling in design of radiopharmaceuticals in various diseases.
rate research
Read More
Glioblastoma is a rapidly evolving high-grade astrocytoma that is distinguished pathologically from lower grade gliomas by the presence of necrosis and microvascular hiperplasia. Necrotic areas are typically surrounded by hypercellular regions known as pseudopalisades originated by local tumor vessel occlusions that induce collective cellular migration events. This leads to the formation of waves of tumor cells actively migrating away from central hypoxia. We present a mathematical model that incorporates the interplay among two tumor cell phenotypes, a necrotic core and the oxygen distribution. Our simulations reveal the formation of a traveling wave of tumor cells that reproduces the observed histologic patterns of pseudopalisades. Additional simulations of the model equations show that preventing the collapse of tumor microvessels leads to slower glioma invasion, a fact that might be exploited for therapeutic purposes.
Certain short polycations, such as TAT and polyarginine, rapidly pass through the plasma membranes of mammalian cells by an unknown mechanism called transduction as well as by endocytosis and macropinocytosis. These cell-penetrating peptides (CPPs) promise to be medically useful when fused to biologically active peptides. I offer a simple model in which one or more CPPs and the phosphatidylserines of the inner leaflet form a kind of capacitor with a voltage in excess of 180 mV, high enough to create a molecular electropore. The model is consistent with an empirical upper limit on the cargo peptide of 40--60 amino acids and with experimental data on how the transduction of a polyarginine-fluorophore into mouse C2C12 myoblasts depends on the number of arginines in the CPP and on the CPP concentration. The model makes three testable predictions.
We outline recent developments in artificial intelligence (AI) and machine learning (ML) techniques for integrative structural biology of intrinsically disordered proteins (IDP) ensembles. IDPs challenge the traditional protein structure-function paradigm by adapting their conformations in response to specific binding partners leading them to mediate diverse, and often complex cellular functions such as biological signaling, self organization and compartmentalization. Obtaining mechanistic insights into their function can therefore be challenging for traditional structural determination techniques. Often, scientists have to rely on piecemeal evidence drawn from diverse experimental techniques to characterize their functional mechanisms. Multiscale simulations can help bridge critical knowledge gaps about IDP structure function relationships - however, these techniques also face challenges in resolving emergent phenomena within IDP conformational ensembles. We posit that scalable statistical inference techniques can effectively integrate information gleaned from multiple experimental techniques as well as from simulations, thus providing access to atomistic details of these emergent phenomena.
We review key considerations, practices, and areas for future work aimed at the responsible development and fielding of AI technologies. We describe critical challenges and make recommendations on topics that should be given priority consideration, practices that should be implemented, and policies that should be defined or updated to reflect developments with capabilities and uses of AI technologies. The Key Considerations were developed with a lens for adoption by U.S. government departments and agencies critical to national security. However, they are relevant more generally for the design, construction, and use of AI systems.
Recent development in AI has enabled the expansion of its application to multiple domains. From medical treatment, gaming, manufacturing to daily business processes. A huge amount of money has been poured into AI research due to its exciting discoveries. Technology giants like Google, Facebook, Amazon, and Baidu are the driving forces in the field today. But the rapid growth and excitement that the technology offers obscure us from looking at the impact it brings on our society. This short paper gives a brief history of AI and summarizes various social, economic and ethical issues that are impacting our society today. We hope that this work will provide a useful starting point and perhaps reference for newcomers and stakeholders of the field.
Log in to be able to interact and post comments
comments
Fetching comments
Sign in to be able to follow your search criteria
